Strategic Partnerships Neeuro collaborates with research institutions and healthcare providers (A*STAR, IMH, Sentosa, Vine Global, Gifted Learners) suggesting a readiness to engage co-development and BCI-enabled therapeutic programs. Sales opportunities include joint pilots, co-branded digital therapeutics, and integration with hospital workflows.

BCI Driven Care Core NeeuroOS platform analyzes brain signals to measure attention, relaxation, workload, and fatigue, supporting ADHD, stroke rehabilitation, and cognitive therapy. Target buyer segments include neuro rehabilitation clinics, pediatric neurology centers, and mental health clinics seeking objective neuromonitoring within digital therapeutics.

Home-Based Programs Recent launches like Cogo and prior emphasis on home-based digital therapeutics indicate demand for remote brain training. Sales focus can be on at-home subscription models, caregiver onboarding, and B2C partnerships with school districts or caregiver networks.

Clinical Validation Clinically validated research backing from A*STAR strengthens credibility for procurement in clinical settings and research trials. Use this to position NeeuroOS as a compliant, evidence-backed solution for hospital procurement and grant-funded pilots.

Growth Constraints Company size is 11-50 employees with revenue in the 0-1M range, signaling a small, agile organization. Opportunities exist for channel partnerships, system integrator enablement, and scalable licensing models to accelerate adoption while aligning with their resource capacity.